Niemann-Pick type C disease and Alzheimer's disease - The APP-endosome connection fattens up

被引:114
作者
Nixon, RA
机构
[1] NYU, Sch Med, Dept Psychiat, Ctr Dementia Res,Nathan Kline Inst, Orangeburg, NY 10962 USA
[2] NYU, Sch Med, Dept Cell Biol, Ctr Dementia Res,Nathan Kline Inst, Orangeburg, NY 10962 USA
关键词
D O I
10.1016/S0002-9440(10)63163-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Niemann-Pick Type C (NPC) is an inherited neurodegenerative disease of childhood and adolescence that develops from a failure of cholesterol trafficking within the endosomal-lysosomal pathway. Although NPC differs in major respects from Alzheimer's disease (AD), intriguing parallels exist in the cellular pathology of these two diseases, including neurofibrillary tangle formation, prominent lysosome system dysfunction, and influences of apolipoprotein E is an element of4 genotype. Added to these similarities are new findings; that some neuronal populations develop abnormalities of endosomes resembling those seen at the earliest stages of AD and also accumulate beta-cleaved amyloid precursor protein (APP) and Abeta peptides within endosomes. in this commentary, the common features of endosome dysfunction are reviewed. Emerging evidence that endosome dysfunction may lead to beta-amyloidogenic APP processing or neurodegeneration by several different means is discussed.
引用
收藏
页码:757 / 761
页数:5
相关论文
共 71 条
[51]   Neurodegeneration in Niemann-Pick type C disease mice [J].
Ong, WY ;
Kumar, U ;
Switzer, RC ;
Sidhu, A ;
Suresh, G ;
Hu, CY ;
Patel, SC .
EXPERIMENTAL BRAIN RESEARCH, 2001, 141 (02) :218-231
[52]   Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4 [J].
Orth, M ;
Mundegar, RR .
NEUROMUSCULAR DISORDERS, 2003, 13 (01) :49-54
[53]  
OsterGranite ML, 1996, J NEUROSCI, V16, P6732
[54]  
PENTCHEV PG, 1995, NIEMANNPICK DIS TYPE, P2625
[55]   Mutagenesis identifies new signals for β-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Aβ42 [J].
Perez, RG ;
Soriano, S ;
Hayes, JD ;
Ostaszewski, B ;
Xia, WM ;
Selkoe, DJ ;
Chen, XH ;
Stokin, GB ;
Koo, EH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :18851-18856
[56]   Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease [J].
Poirier, J .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (03) :94-101
[57]  
Reaves BJ, 2000, J CELL SCI, V113, P4099
[58]   Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model [J].
Refolo, LM ;
Pappolla, MA ;
Malester, B ;
LaFrancois, J ;
Bryant-Thomas, T ;
Wang, R ;
Tint, GS ;
Sambamurti, K ;
Duff, K .
NEUROBIOLOGY OF DISEASE, 2000, 7 (04) :321-331
[59]   Trafficking defects in endogenously synthesized cholesterol in fibroblasts, macrophages, hepatocytes, and glial cells from Niemann-Pick type C1 mice [J].
Reid, PC ;
Sugii, S ;
Chang, TY .
JOURNAL OF LIPID RESEARCH, 2003, 44 (05) :1010-1019
[60]   Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells [J].
Runz, H ;
Rietdorf, J ;
Tomic, I ;
de Bernard, M ;
Beyreuther, K ;
Pepperkok, R ;
Hartmann, T .
JOURNAL OF NEUROSCIENCE, 2002, 22 (05) :1679-1689